Novelty DNA Tests: A Buyer Beware Guide

A saliva sample can tell you a great deal about your ancestry, a handful of well-validated disease risk markers, and the rough outlines of your maternal and paternal lineages. It cannot, as of early 2026, tell you which wine to order, which serum to put on your face, or which sport your child should play. A whole shelf of consumer products claims otherwise. This is the category we call novelty DNA tests, and it deserves a category-level warning before any individual review.

We are not saying every novelty test is a scam. We are saying the category sits in a regulatory grey zone where the marketing routinely outruns the science, and the patterns that distinguish a marketing claim from a tested one are learnable.

What we mean by “novelty”

A novelty DNA test, in our usage, is one that sells personalized lifestyle-product recommendations on the basis of a small panel of common genetic variants. The recommendation can be a diet plan, a skincare routine, a wine subscription, a workout program, or an “athletic potential” report for a child. The common thread is that the test’s value proposition is prescriptive guidance for everyday decisions, derived from genetics that, on inspection, explain a small fraction of variance in the outcome.

Legitimate consumer tests exist on the same shelf. AncestryDNA and 23andMe report on things that are genuinely heritable and genuinely measurable. FDA-authorized health reports cover a narrow set of well-validated variants with explicit caveats. Whole-genome sequencing reads your actual DNA. Those are not what we mean here.

Red flags that mark a novelty test

A small list, drawn from the FTC’s own enforcement record and the American College of Medical Genetics and Genomics’ position on direct-to-consumer testing.

A tiny gene list, presented as comprehensive. If the marketing copy mentions “30 key genes” or “the most important variants,” that is a genotyping panel, not a full genome. Diet, athletic performance, and skincare are not controlled by 30 variants. Real lifestyle traits are polygenic and environmental, often heavily so.

Vague effect-size language. Phrases like “your genes suggest” or “you may benefit from” are doing real work. The science behind a serious finding gives an odds ratio, a percentage of variance explained, or a population attributable risk. The science behind a novelty test usually gives the word “may.”

Bundled product recommendations. When the test sells you, or upsells you to, a vitamin pack, a serum, a wine club, or a meal kit “matched” to your results, the financial incentive of the company is to find something to match you to. The FTC’s Health Products Compliance Guidance specifically requires competent and reliable scientific evidence for claims of this shape, and the agency has acted when that evidence was missing.

No peer-reviewed validation. Real tests publish or cite validation studies showing that the test’s call matches an outcome people care about. Novelty tests usually cite the underlying genetics research, not a validation of their own product.

“Personalized” routines that are generic on inspection. The skincare advice often reduces to “wear sunscreen, use retinoids, moisturize.” The diet advice often reduces to “eat more vegetables, reduce refined sugar.” Standard public health advice presented as a personal recommendation is the oldest trick in the category.

The FTC enforcement record

Federal Trade Commission case files are the cleanest evidence base here, because they are conclusions reached after investigation rather than opinions. In 2023 the FTC settled with Vitagene, Inc., a DNA-based personalized wellness company, over allegations that the company made unsupported health claims and failed to adequately protect sensitive genetic data. The order requires substantiation for future health claims and specific data-security commitments. Earlier enforcement actions covered DNA companies marketing diet, anti-aging, and pharmacogenomic products. The pattern across cases is the same: prescriptive lifestyle claims that the agency found were not backed by competent and reliable scientific evidence.

What this means for a buyer

We do not pretend the novelty market is going away. Curiosity-driven purchases are part of why consumer genetics exists at all. We think a buyer should know three things before they spend money.

First, the FDA does not currently authorize direct-to-consumer genetic tests for lifestyle prescription. The FDA’s guidance on direct-to-consumer tests is specific to health and disease risk reports, and the authorizations are for narrow indications. A diet or skincare recommendation is not within that framework.

Second, if a test makes a health-adjacent claim, the burden of proof is on the seller, not on you. If they cannot point you to a peer-reviewed validation of the test’s own predictive value, treat the claim as marketing.

Third, the legitimate, well-validated consumer DNA tests are documented elsewhere on this site. Start with our guide to choosing a DNA test, our explainer on DNA test accuracy, and the buying mistakes to avoid piece. For the specific novelty categories, see our diet tests piece, the athletic and talent tests explainer, and the skincare tests walkthrough.

If a result from any DNA test raises a health question for you, the National Society of Genetic Counselors directory lets you find a board-certified counselor. That conversation is worth more than any algorithm.